Morningstar Investor users sign in here.

Company Profile

  • Business description

    Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

  • Contact

    1868-1892 Dandenong Road
    Clayton VIC 3168
    AUS

    T: +61 395386777

    https://www.clinicallabs.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2025

    Employees

Australian Clinical Labs Ltd News & Analysis

stocks

Market is underestimating ASX pathology shares

Morningstar sees several reasons to expect a stronger recover than market consensus.
stocks

3 ASX small caps with bright futures

Simon Conn of Investors Mutual says small caps are poised for a turnaround and there are three stocks that he likes right now. 
markets

Why this bull market can't last

Schroders' Australian equity team say investors piling into tech stocks again are ignoring a turning point in markets.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,206.10 72.70 0.89%
CAC 40 7,724.32 97.19 1.27%
DAX 40 18,748.18 213.62 1.15%
Dow JONES (US) 40,000.90 247.15 0.62%
FTSE 100 8,252.91 29.57 0.36%
HKSE 18,293.38 461.05 2.59%
NASDAQ 18,398.45 115.04 0.63%
Nikkei 225 41,190.68 1,033.34 -2.45%
NZX 50 Index 12,134.97 76.68 0.64%
S&P 500 5,615.35 30.81 0.55%
S&P/ASX 200 7,959.30 69.70 0.88%
SSE Composite Index 2,971.29 0.91 0.03%

Market Movers

We’re currently having some problems with our data feed. We apologise for any inconvenience.